KT&G aims for over half of sales from overseas business

Jan.28.2023
KT&G aims for over half of sales from overseas business
KT&G aims to gain over half of its sales revenue from overseas operations by 2027.

During an investor event, KT&G announced its goal of generating more than 50% of its sales revenue from overseas operations by 2027.


The goal of this South Korean cigarette manufacturer is to achieve sales of 10 trillion Korean won ($8.1 billion) in a year, with a projected annual sales of 5.9 trillion Korean won ($4.8 billion) by 2022. Last year, approximately one-third of KT&G's sales may have come from foreign markets.


Bang Kyung-man, the executive vice president of KT&G, has announced that the company will not only focus on its combustible tobacco business but also strengthen its next-generation product (NGP) business, including heated tobacco products (HnB) and functional foods for health.


He stated, "We will invest KRW 40 trillion and construct new overseas production facilities over the next five years, while expanding existing facilities, to meet the continuous growth in NGP demand, such as HnB products.


Bang stated that the company is considering building a new factory in Kazakhstan or Eastern Europe. He mentioned that in order to raise the necessary funds, the company plans to sell unused properties and borrow from banks.


Since signing an agreement with PhiMo International in 2020 to commercialize KT&G's smoke-free products outside of Korea, KT&G has exported its HnB products to over 30 countries.


Currently, 90% of KT&G's revenue comes from cigarette sales, with the remaining 10% coming from their HnB products. The company has four tobacco manufacturing plants in South Korea, Russia, Turkey, and Indonesia, with a total annual production capacity of 13.6 billion cigarettes.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

KT&G Integrates “lil Aible” Dedicated Stick Lineup Under the “AIIM” Brand
KT&G Integrates “lil Aible” Dedicated Stick Lineup Under the “AIIM” Brand
KT&G said it will integrate the Real, Granular and Vapor Stick product lines for its heated tobacco device “lil Aible” under the “AIIM” brand. The company said the brand integration is intended to organize the existing lineup more intuitively and improve consumer accessibility and convenience.
Mar.18 by 2FIRSTS.ai
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp, an online retailer of alternative nicotine products, has confirmed it is exiting the UK vape category as it shifts focus to the oral nicotine market. The company said analysis of its sales data showed increasing adoption of nicotine pouches across its six international markets: the UK, the USA, Germany, Norway, Switzerland and Sweden.
Mar.04 by 2FIRSTS.ai
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Azerbaijan Cancels E-Cigarette State Standard as Full Vape Ban Takes Effect on April 1
Azerbaijan Cancels E-Cigarette State Standard as Full Vape Ban Takes Effect on April 1
The Azerbaijan Institute of Standardization (AZSTAND) has announced the cancellation of state standard AZS 941:2023, “Electronic Cigarettes. General Technical Specifications.”Under legal amendments adopted on December 30, 2025, Azerbaijan has prohibited from April 1, 2026 the import, export, manufacture, storage, wholesale and retail sale, and use of e-cigarettes and their components.
Apr.07 by 2FIRSTS.ai
BAT FY2025 Results Review Series by 2Firsts
BAT FY2025 Results Review Series by 2Firsts
Feb.12